Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04920383
Title ALPN-202 With PD-1 Inhibition in Advanced Malignancies (NEON-2)
Acronym NEON-2
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alpine Immune Sciences, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.